Role of Drug-coated Balloons in Small-vessel Coronary Artery Disease

Q4 Medicine

US Cardiology Review Pub Date : 2019-01-27 DOI:10.15420/USC.2019.4.1

M. Megaly, M. Saad, E. Brilakis

引用次数: 3

Abstract

Percutaneous coronary intervention of small-vessel coronary artery disease (SVD) remains challenging due to difficulties with device delivery and high restenosis rate, even with the use of newer-generation drug-eluting stents. Drug-coated balloons represent an attractive emerging percutaneous coronary intervention option in patients with SVD. Potential advantages of drug-coated balloons in SVD include enhanced deliverability because of their small profile, avoidance of foreign-body implantation, and shorter duration of dual antiplatelet therapy.

查看原文本刊更多论文

药物包被球囊在小血管冠状动脉疾病中的作用

小血管冠状动脉疾病（SVD）的经皮冠状动脉介入治疗仍然具有挑战性，因为即使使用新一代药物洗脱支架，装置递送困难且再狭窄率高。药物涂层球囊是一种有吸引力的新兴经皮冠状动脉介入治疗SVD患者的选择。药物包被球囊在SVD中的潜在优势包括由于其体积小而提高了递送能力，避免了异物植入，以及缩短了双重抗血小板治疗的持续时间。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

US Cardiology Review Medicine-Cardiology and Cardiovascular Medicine

CiteScore

1.10

自引率

0.00%

发文量

审稿时长

10 weeks

期刊介绍： US Cardiology Review (USC) is an international, US-English language, peer-reviewed journal that is published bi-annually and aims to assist time-pressured physicians to stay abreast of key advances and opinion in the area of cardiovascular disease. The journal comprises balanced and comprehensive review articles written by leading authorities. The journal provides updates on a range of salient issues to support physicians in developing their knowledge and effectiveness in day-to-day clinical practice. The journal endeavours to support the continuous medical education of specialist and general cardiologists and disseminate knowledge of the field to the wider cardiovascular community.